Denali Therapeutics (4DN.F) Q4 2024 Earnings

Nov 6Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.79
-0.71
-0.63
-0.55

Details

Expected EPS
-0.54610624926
Actual EPS
-0.5781699
Surprise EPS
-0.03
Surprise Percent
-5.87%

Description

⁨Denali Therapeutics⁩ (⁦4DN.F⁩) has reported earnings of ⁦-0.5781699⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts